R. Townsend
Algemeen Directeur bij LEXEO THERAPEUTICS, INC.
Vermogen: 3 M $ op 31-05-2024
Profiel
R.
Nolan Townsend is currently the Chief Executive Officer & Director at Lexeo Therapeutics, Inc., the Director at Biotechnology Innovation Organization, and the Director at Arbor Biotechnologies, Inc. Previously, he served as the Chairman at Life Science Cares New York from 2022 to 2024 and as a Principal at Pfizer Inc. from 2008 to 2020.
He completed his undergraduate degree at the University of Pennsylvania in 2002 and earned an MBA from Harvard Business School in 2007.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LEXEO THERAPEUTICS, INC.
0.52% | 10-06-2024 | 170 695 ( 0.52% ) | 3 M $ | 31-05-2024 |
Actieve functies van R. Townsend
| Bedrijven | Functie | Begin |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Algemeen Directeur | 01-01-2020 |
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | 01-10-2023 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Bestuurslid | 01-10-2023 |
Eerdere bekende functies van R. Townsend
| Bedrijven | Functie | Einde |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01-01-2020 |
Opleiding van R. Townsend
| University of Pennsylvania | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| LEXEO THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
